{"disease":{"id":"chronic-obstructive-pulmonary-disease-copd","name":"chronic obstructive pulmonary disease copd"},"drugs":{"marketed":[{"drug_id":"atm-avi","indication_name":"Treatment of acute bacterial exacerbation of chronic obstructive pulmonary disease (ABECOPD) caused by Haemophilus influenzae, Haemophilus parainfluenzae, or Moraxella catarrhalis.","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Atm-Avi","generic_name":"atm-avi","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"unknown","drug_class":"antibiotic","quality_score":37,"revenue":null,"mechanism":"ATM-AVI's mechanism of action is not specified on Wikipedia."},{"drug_id":"atm-avi","indication_name":"Treatment of acute bacterial exacerbation of chronic obstructive pulmonary disease (ABECOPD) caused by Haemophilus influenzae, Haemophilus parainfluenzae, or Moraxella catarrhalis in patients who have a penicillin tolerance test result of >= 20 mcg/mL.","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Atm-Avi","generic_name":"atm-avi","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"unknown","drug_class":"antibiotic","quality_score":37,"revenue":null,"mechanism":"ATM-AVI's mechanism of action is not specified on Wikipedia."},{"drug_id":"ensifentrine","indication_name":"chronic obstructive pulmonary disease (COPD)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ohtuvayre","generic_name":"ENSIFENTRINE","company_name":"Verona Pharma","drug_phase":"marketed","molecular_target":"","drug_class":"Phosphodiesterase 3 Inhibitor [EPC]","quality_score":47,"revenue":null,"mechanism":"Ohtuvayre works by blocking an enzyme called phosphodiesterase 3, which helps to increase the levels of a molecule called cyclic AMP in the lungs."},{"drug_id":"carbocysteine","indication_name":"Reduction of sputum viscosity in chronic obstructive pulmonary disease (COPD)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Mucodyne","generic_name":"carbocysteine","company_name":"","drug_phase":"marketed","molecular_target":"Mucus glycoprotein synthesis","drug_class":"Mucolytic","quality_score":24,"revenue":null,"mechanism":""},{"drug_id":"ppsv23","indication_name":"Prevention of invasive disease caused by Streptococcus pneumoniae in adults 2 years of age or older with chronic lung disease, including chronic obstructive pulmonary disease (COPD) and asthma","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ppsv23","generic_name":"ppsv23","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Streptococcus pneumoniae","drug_class":"Vaccine","quality_score":45,"revenue":null,"mechanism":""}],"pipeline":[{"drug_id":"scopolamine","indication_name":"Chronic obstructive pulmonary disease (COPD)","indication_type":"pipeline","phase":"Phase 2","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"SCOPOLAMINE","company_name":"","drug_phase":"marketed","molecular_target":"Muscarinic acetylcholine receptors","drug_class":"Anticholinergic [EPC]","quality_score":55,"revenue":null,"mechanism":""}],"offLabel":[],"totalMarketed":5,"totalPipeline":1},"trials":{"data":[{"nct_id":"NCT04966637","title":"Identifying Early Chronic Obstructive Pulmonary Disease (COPD) Using Health Administrative Data","phase":"","overall_status":"COMPLETED","enrollment_count":54028,"lead_sponsor_name":"University of Alberta","has_results":false},{"nct_id":"NCT04684836","title":"Comparative Effectiveness of Telemedicine in Primary Care","phase":"","overall_status":"COMPLETED","enrollment_count":33100,"lead_sponsor_name":"Weill Medical College of Cornell University","has_results":true},{"nct_id":"NCT06685315","title":"Research on the Characteristics of Chronic Airway Diseases (asthma, COPD)","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":10545,"lead_sponsor_name":"Henan University of Traditional Chinese Medicine","has_results":false},{"nct_id":"NCT03359122","title":"Association of COPD Maintenance Medication Adherence With Resource Use and Cost Among COPD Patients","phase":"","overall_status":"COMPLETED","enrollment_count":10067,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT07382986","title":"IMPACT COPD Cohort (China)","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Beijing Chao Yang Hospital","has_results":false},{"nct_id":"NCT05952999","title":"Analysis of the Virtual Acute Care at Home Experience","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":9654,"lead_sponsor_name":"OSF Healthcare System","has_results":false},{"nct_id":"NCT03131362","title":"Realize the Current Situation of COPD Patients in China","phase":"","overall_status":"COMPLETED","enrollment_count":5020,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT03581227","title":"The CAPTURE Study: Validating a Unique COPD Case Finding Tool in Primary Care (Aim 1)","phase":"","overall_status":"COMPLETED","enrollment_count":4679,"lead_sponsor_name":"Weill Medical College of Cornell University","has_results":false},{"nct_id":"NCT06583395","title":"Quest to Analyze One Thousand Humans Meditating","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":3000,"lead_sponsor_name":"Tobias Moeller-Bertram","has_results":false},{"nct_id":"NCT07457073","title":"AI-Powered Sound Analysis for COPD Screening","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Sir Run Run Shaw Hospital","has_results":false},{"nct_id":"NCT07518446","title":"Somatic Health Screening for Adults in Outpatient Psychiatric Care in Denmark (SomaScreen)","phase":"NA","overall_status":"RECRUITING","enrollment_count":2800,"lead_sponsor_name":"Amager Hospital","has_results":false},{"nct_id":"NCT04301505","title":"Improvement in COPD Elderly Patients Health: Study Protocol","phase":"NA","overall_status":"COMPLETED","enrollment_count":2520,"lead_sponsor_name":"Medical University of Lodz","has_results":false},{"nct_id":"NCT03583099","title":"The CAPTURE Study: Validating a Unique COPD Case Finding Tool in Primary Care (Aim 3)","phase":"NA","overall_status":"COMPLETED","enrollment_count":2004,"lead_sponsor_name":"Weill Medical College of Cornell University","has_results":true},{"nct_id":"NCT06892210","title":"Comparing Hydrocortisone and Prednisolone for Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD)","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Copenhagen Respiratory Research","has_results":false},{"nct_id":"NCT06798077","title":"Chronic Airway Disease and Multimorbidity Cohort","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"China-Japan Friendship Hospital","has_results":false},{"nct_id":"NCT07180368","title":"Assessment and Management of Multiple Drug Use in Elderly Chronic Disease Patients","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Xijing Hospital","has_results":false},{"nct_id":"NCT05742802","title":"Long-term Efficacy and Safety of Tozorakimab in Participants With Chronic Obstructive Pulmonary Disease With a History of Exacerbations (PROSPERO).","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1713,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT06992921","title":"Towards Personalized Nutrition With SCAPIS2-HOME","phase":"NA","overall_status":"COMPLETED","enrollment_count":1641,"lead_sponsor_name":"Chalmers University of Technology","has_results":false},{"nct_id":"NCT02579850","title":"2-arm Parallel Group Study of Fixed Combination of CHF 5993 vs Ultibro® in COPD Patients","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1532,"lead_sponsor_name":"Chiesi Farmaceutici S.p.A.","has_results":false},{"nct_id":"NCT07221981","title":"Study of Patient With Frequent COPD Exacerbations","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1519,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT06040086","title":"Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1454,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT02165826","title":"Evaluation of Tolerability and Pharmacokinetics of Roflumilast, 250μg and 500μg, as add-on to Standard COPD Treatment to Treat Severe COPD","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1323,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT05595642","title":"A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":1290,"lead_sponsor_name":"Hoffmann-La Roche","has_results":false},{"nct_id":"NCT05158387","title":"Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1172,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT07082738","title":"A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":1160,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT05166889","title":"Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1132,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT03162055","title":"Efficacy and Safety of Glycopyrronium/Formoterol Fumarate Fixed-dose Combination Relative to Umeclidinium/Vilanterol Fixed-dose Combination Over 24 Weeks in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1119,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT02603393","title":"Evaluation of the Efficacy and Safety of QVA149 (110/50 μg o.d.) vs Tiotropium (18 µg o.d.) + Salmeterol/Fluticasone Propionate FDC (50/500 µg b.i.d.) in Patients With Moderate to Severe COPD","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":1053,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT07183657","title":"Adherence to Inhaled Therapy - a Globally Overlooked Problem in Patients With Chronic Obstructive Pulmonary Disease and Bronchial Asthma","phase":"NA","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Charles University, Czech Republic","has_results":false},{"nct_id":"NCT07102823","title":"Clinical Registry for the Characterization of the 'Pulmonary Vascular Phenotype' in Patients With Chronic Obstructive Pulmonary Disease","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Medical University of Graz","has_results":false},{"nct_id":"NCT06933758","title":"Temple Health Chest Initiative (THCI 2.0)","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Temple University","has_results":false},{"nct_id":"NCT06878261","title":"A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":990,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT06883305","title":"A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":990,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT05330637","title":"Study on the Influence of Climatic and Environmental Factors on Respiratory Diseases in Sanya, Hainan Province, China.","phase":"","overall_status":"UNKNOWN","enrollment_count":800,"lead_sponsor_name":"Shanghai Jiao Tong University School of Medicine","has_results":false},{"nct_id":"NCT06678191","title":"Investigation of Fixed Triple Inhaled Combination in Asthmatic Patients, in a Real-life Setting","phase":"","overall_status":"RECRUITING","enrollment_count":800,"lead_sponsor_name":"Chiesi Hungary Ltd.","has_results":false},{"nct_id":"NCT06376994","title":"Multi-Center Clean Air Randomized Controlled Trial in COPD","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":770,"lead_sponsor_name":"JHSPH Center for Clinical Trials","has_results":false},{"nct_id":"NCT06321731","title":"Real-World Outcomes in COPD Patients Starting Trixeo (Budesonide/Glycopyrronium/Formoterol) in Spain.","phase":"","overall_status":"COMPLETED","enrollment_count":718,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT06653413","title":"Exploring the Diagnostic Performance of Dynamic Chest Radiology in Chronic Obstructive Pulmonary Disease","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":600,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT03011515","title":"Evaluating a Host-response Based Diagnostic for Distinguishing Between Bacterial and Viral Etiology in Patients With Lower Respiratory Tract Infection (LRTI)","phase":"","overall_status":"COMPLETED","enrollment_count":583,"lead_sponsor_name":"MeMed Diagnostics Ltd.","has_results":false},{"nct_id":"NCT01415518","title":"Efficacy and Tolerability Study in Severe Chronic Obstructive Pulmonary Disease (COPD) Patients","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":581,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT05573464","title":"A Study to Assess the Safety of Budesonide/Glycopyrronium/Formoterol Fumarate With a Next-Generation Propellant in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":559,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT07412418","title":"Screening for Pulmonary Embolism Using Single-channel Electrocardiogram","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":500,"lead_sponsor_name":"I.M. Sechenov First Moscow State Medical University","has_results":false},{"nct_id":"NCT02983812","title":"Developing Enhanced Prediction Models","phase":"","overall_status":"COMPLETED","enrollment_count":500,"lead_sponsor_name":"University of Pennsylvania","has_results":false},{"nct_id":"NCT07380711","title":"Long-term Real-world Study of Dupilumab in COPD : Patient Characteristics, Safety and Patient-reported Outcomes","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Sanofi","has_results":false},{"nct_id":"NCT07307781","title":"Study of Patient With Frequent Exacerbations in Moscow","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT06643078","title":"A Study to Evaluate the Safety and Efficacy of HL231 Solution for Inhalation in Patients With COPD","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":487,"lead_sponsor_name":"Haisco Pharmaceutical Group Co., Ltd.","has_results":false},{"nct_id":"NCT06670118","title":"Exploring the Correlations of Lung Ultrasound with Delirium and Outcomes in Acute GEriatrics World: a Multicenter, Prospective, Observational Study from the GRETA Group of the Italian Society of Gerontology and Geriatrics","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":480,"lead_sponsor_name":"University of Milano Bicocca","has_results":false},{"nct_id":"NCT07134855","title":"Mitigating Chronic Respiratory Disease Through the Lens of Multimorbidity (MARES3)","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":473,"lead_sponsor_name":"University College, London","has_results":false},{"nct_id":"NCT06952881","title":"A Study on COPD Phenotypes, Endotypes and Treatable Traits","phase":"","overall_status":"RECRUITING","enrollment_count":460,"lead_sponsor_name":"Chinese University of Hong Kong","has_results":false},{"nct_id":"NCT06453382","title":"Development and Testing of a Sub-district Specific Model of 'Whole-of-government', and 'Whole-of-society' Approaches for the Prevention and Control of Non-communicable Diseases in a Sub-district of Bangladesh","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":450,"lead_sponsor_name":"BRAC University","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}